Glaxo Operations UK Limited, operating as Glaxo Wellcome Operations (Manufacturer of unpackaged product, quality control of finished product)

The drug is intended for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) who are infected with the human immunodeficiency virus (HIV). It is used in combination with other antiretroviral agents.

Dosage form: tablets, film-coated

ATC: J05AJ03